secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001079973-25-000774
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TOI shareholders approve reverse stock split up to 1:40; re-elect all 8 directors
--------------------------------------------------------------------------------

- Reverse stock split approved at ratio between 1:5 and 1:40, board discretion within one year.
- All eight director nominees elected; Richard Barasch received 39.2M votes for, 654k withheld.
- Ratification of BDO USA as auditor for FY2025 approved with 61.2M for, 682k against.
- Turnout of 61.9M shares representing 81.7% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/0001079973-25-000774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-000774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer